VACcination In Methotrexate Treated Rheumatoid Arthritis Patients
Status:
Completed
Trial end date:
2019-07-10
Target enrollment:
Participant gender:
Summary
To estimate the rate of immunological answer 1 month after antipneumococcal vaccination by
the conjugated vaccine Prevenar13 ® in patients suffered from rheumatoid polyarthritis and
who begin a treatement by methotrexate either in the same time, either 1 month later.